APM
Niki BioSolutions, Inc.Price
Daily candles with volume.
Signal stack
Where each data set points today.
- Short sellersSTEADY
Short interest +7.1% to 66.9K shares. 3.9 days to cover, ≈0.8% of shares.
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current FY | — | — | — | $0.00 |
| Next FY | — | — | — | $0.00 |
| Current Q | — | — | — | $0.00 |
| Next Q | — | — | — | $0.00 |
Short side
FINRA· Jul 15, 2026| Jul 17, 2026 | Deletion | Resumed |
SecBot reports
8 filings · 2 press releases · 0 bullish · 4 bearish · 4 neutral- NEUTRAL 8-KOct 13, 2026
Niki BioSolutions appointed Thomas Freeburg as CFO effective September 1, 2026, with a two-year…
Monitor Niki BioSolutions' capital-raising progress, as the CFO's deferred salary and salary increase are tied to $3M and $5M cumulative capital investments, respectively.
- BEARISH 8-KOct 9, 2026
Niki BioSolutions, Inc. entered into an At the Market Offering Agreement with H.C. Wainwright &…
Monitor the company's periodic filings (10-Q/10-K) for disclosure of actual shares sold under the ATM program and the use of proceeds. The conflict of interest with a director serving as a managing…
- BEARISH 424B5Oct 9, 2026
Niki BioSolutions filed a 424B5 prospectus supplement for an at-the-market (ATM) equity offering…
The ATM offering provides near-term cash but at the cost of immediate dilution. Monitor the pace of share sales under the ATM — rapid issuance at current depressed prices (~$4.23) signals acute cash…
- NEUTRAL 8-KJul 20, 2026
Aptorum Group (APM) completed its merger with DiamiR Biosciences on July 20, 2026, after…
The merger creates a new diagnostics-focused entity with a small float and concentrated ownership via the Stockholders Agreement. Monitor the first combined quarterly report for revenue and cash…
All APM filing & press-release reports (10)
- 8-K reportOct 13, 2026
- 8-K reportOct 9, 2026
- 424B5 reportOct 9, 2026
- 8-K reportJul 20, 2026
- PRESS-RELEASE reportJul 16, 2026
- 6-K reportJun 10, 2026
- EFFECT reportJun 4, 2026
- 6-K reportMay 14, 2026
- 20-F reportMar 27, 2026
- PRESS-RELEASE reportMar 6, 2026